Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
75 hedge funds and large institutions have $95.5M invested in Ampio Pharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
130% more capital invested
Capital invested by funds: $41.6M → $95.5M (+$53.9M)
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
9% more funds holding
Funds holding: 69 → 75 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
51% less call options, than puts
Call options by funds: $3.49M | Put options by funds: $7.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$2.17M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.04M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$818K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$725K |
| 5 |
GMCM
Gruber & McBaine Capital Management
San Francisco,
California
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
Talkot Capital
Sausalito,
California
|
-$2.69M |
| 2 |
Morgan Stanley
New York
|
-$748K |
| 3 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$435K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$344K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$273K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
76
Credit Suisse
Zurich,
Switzerland
| – | -$273K | -265 | Closed |
|
|
CIA
77
Capital Impact Advisors
Boston,
Massachusetts
| – | -$79K | -76 | Closed |
|
78
Millennium Management
New York
| – | -$71K | -69 | Closed |
|
|
AGM
79
Alpine Global Management
New York
| – | -$54K | -52 | Closed |
|
|
SAIG
80
Semper Augustus Investments Group
Highlands Ranch,
Colorado
| – | -$34K | -33 | Closed |
|
AMPE Hedge Fund Activity: Q1 2015 in Review
75 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2015, worth a combined $95.5M — up 130% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new AMPE positions and 5 closed out — a net gain of 7 holders — while 25 added to existing stakes and 17 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $2.17M. The largest seller was Talkot Capital, cutting an estimated $2.69M.
- 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2015, up from 69 in Q4 2014.
- Funds reported $95.5M of Ampio Pharmaceuticals Inc. stock for Q1 2015, up 130% quarter-over-quarter.
- 12 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2015 and 5 closed out, a net change of +7 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2015 was EAM Investors, an estimated $2.17M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2015 was Talkot Capital, an estimated $2.69M sold.
Based on aggregated 13F filings for Q1 2015.